1. Han, Lisa, Liu, Yajuan J, Ricciotti, Robert W, Mantilla, Jose G. 2020. A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review. In Genes, chromosomes & cancer, 59, 428-432. doi:10.1002/gcc.22845. https://pubmed.ncbi.nlm.nih.gov/32237188/
2. Mikhaylenko, Nathan, Wahnschaffe, Linus, Herling, Marco, Roeder, Ingo, Seifert, Michael. 2022. Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia. In PloS one, 17, e0274463. doi:10.1371/journal.pone.0274463. https://pubmed.ncbi.nlm.nih.gov/36129940/
3. Li, Jie, Galbo, Phillip M, Gong, Weida, Zheng, Deyou, Wang, Gang Greg. 2021. ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism. In Nature communications, 12, 1045. doi:10.1038/s41467-021-21357-3. https://pubmed.ncbi.nlm.nih.gov/33594072/
4. Devoucoux, Maëva, Fort, Victoire, Khelifi, Gabriel, Hussein, Samer M I, Côté, Jacques. . Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes. In Cell reports, 39, 110947. doi:10.1016/j.celrep.2022.110947. https://pubmed.ncbi.nlm.nih.gov/35705031/
5. Zhang, Heng, Devoucoux, Maëva, Song, Xiaosheng, Côté, Jacques, Min, Jinrong. . Structural Basis for EPC1-Mediated Recruitment of MBTD1 into the NuA4/TIP60 Acetyltransferase Complex. In Cell reports, 30, 3996-4002.e4. doi:10.1016/j.celrep.2020.03.003. https://pubmed.ncbi.nlm.nih.gov/32209463/
6. Dewaele, Barbara, Przybyl, Joanna, Quattrone, Anna, Cools, Jan, Debiec-Rychter, Maria. 2013. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. In International journal of cancer, 134, 1112-22. doi:10.1002/ijc.28440. https://pubmed.ncbi.nlm.nih.gov/23959973/
智鼠故事 
